8-K: Horizon Tech Finance to Merge with Monroe Capital

Horizon Technology Finance Corporation and Monroe Capital Corporation announce a definitive merger agreement, creating a combined entity focused on technology and life science debt investments.

Summary

• Horizon Technology Finance Corporation (HRZN) and Monroe Capital Corporation (MRCC) have entered into a definitive Agreement and Plan of Merger.
• The merger will occur in two steps: first, HRZN's wholly-owned subsidiary, Merger Sub, will merge into MRCC, with MRCC surviving as a wholly-owned subsidiary of HRZN; immediately thereafter, MRCC will merge into HRZN, with HRZN continuing as the surviving company.
• Each outstanding share of MRCC common stock will be converted into a number of HRZN common shares based on an Exchange Ratio, calculated as MRCC's Net Asset Value (NAV) per share divided by HRZN's NAV per share, determined no earlier than 48 hours prior to the merger's effective time.
• No fractional shares of HRZN common stock will be issued; holders of MRCC common stock will receive cash in lieu of fractional shares.
• The boards of directors of both HRZN and MRCC, including their independent directors and special committees, have unanimously approved the merger.
• The parties intend for the mergers to be treated as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
• As a condition to the merger, MRCC will sell substantially all of its assets to Monroe Capital Income Plus Corporation (MCIP) for cash, immediately prior to the merger, under a separate Asset Purchase Agreement.
• Horizon Technology Finance Management LLC (HRZN Advisor) has agreed to waive an aggregate of $4.0 million in Base Management Fees and/or Incentive Fees, at a rate of $1.0 million per quarter for four quarters, commencing after the merger's closing.

Sentiment

Score: 8

Explanation: The announcement of a definitive merger agreement, coupled with unanimous board approvals, a significant fee waiver from the advisor, and the intention for a tax-free reorganization, indicates a strong positive strategic move for both companies. While subject to closing conditions, the terms appear favorable and well-planned.

Positives

• The merger has received unanimous approval from the boards of directors of both HRZN and MRCC, including their respective independent directors and special committees, indicating strong internal support.
• HRZN Advisor's commitment to waive $4.0 million in management and incentive fees post-merger is expected to benefit the combined entity's financial performance.
• The transaction is structured to be a tax-free reorganization for U.S. federal income tax purposes, which is beneficial for shareholders.
• The merger is designed to comply with Rule 17a-8 of the Investment Company Act of 1940, ensuring that the interests of existing stockholders will not be diluted.

Risks

• The consummation of the merger is subject to various closing conditions, including requisite approvals from HRZN and MRCC stockholders, regulatory approvals (e.g., HSR Act), and the absence of certain legal impediments.
• There is a risk that the expected synergies and savings associated with the proposed transactions may not be fully realized.
• The ability to realize the anticipated benefits of the proposed transactions is not assured.
• Governmental entities may prohibit, delay, or refuse to grant approval for the consummation of the proposed transactions, or may require conditions, limitations, or restrictions.
• Competing offers or acquisition proposals could be made for either HRZN or MRCC, potentially disrupting the current merger plan.
• The merger process may divert management's attention from ongoing business operations.
• Shareholder litigation in connection with the proposed transactions may result in significant costs of defense and liability.
• Changes in the economy, financial markets, and political environment, including the impacts of inflation and interest rates, could adversely affect the combined entity.
• Risks associated with possible disruption due to terrorism, war, natural disasters, tariffs, or public health crises and epidemics.
• Future changes in laws or regulations (including their interpretation by regulatory authorities) could impact the business.
• Conditions in the operating areas of Business Development Companies (BDCs) or regulated investment companies could change adversely.
• There is no assurance that the market price of HRZN's shares will increase as a result of the merger or any share repurchases.

Future Outlook

The companies anticipate the merger to close during the fourth quarter of 2025, subject to shareholder and regulatory approvals. The transaction is intended to be a tax-free reorganization, and HRZN Advisor will implement a $4.0 million fee waiver post-closing, aiming to enhance the combined entity's financial strength and market profile.

Management Comments

• The boards of directors of both HRZN and MRCC, including their respective independent directors, unanimously determined that the merger agreement and transactions are advisable and in the best interests of their respective companies.
• The boards also determined that the interests of existing stockholders would not be diluted as a result of the transactions, as provided under Rule 17a-8 of the Investment Company Act.

Industry Context

This merger represents a consolidation within the Business Development Company (BDC) sector, particularly for firms specializing in technology and life science debt investments. Such mergers often aim to achieve greater scale, operational efficiencies, and a more diversified portfolio, which are common trends in the BDC industry to enhance shareholder value and market competitiveness.

Management Changes

Corporate Governance

Legal Proceedings

• No material proceedings are pending or, to the knowledge of management, threatened against HRZN or any of its Consolidated Subsidiaries.
• No material proceedings are pending or, to the knowledge of management, threatened against MRCC or any of its Consolidated Subsidiaries.
• Shareholder litigation in connection with the proposed transactions is identified as a potential risk.

Related Party Transactions

• The Asset Purchase Agreement, dated August 7, 2025, between MRCC, Monroe Capital Income Plus Corporation (MCIP), and MRCC Advisor, where MRCC will sell substantially all of its assets to MCIP for cash, is a related party transaction and a condition to the merger.

Stakeholder Impact

• Shareholders of MRCC will receive HRZN common stock, potentially benefiting from the combined entity's scale and the HRZN Advisor fee waiver.
• Shareholders of HRZN will see their ownership diluted by the issuance of new shares but may benefit from a larger, more diversified asset base and the fee waiver.
• Management of both companies will be involved in the integration process, with HRZN's CEO and two independent directors retaining their roles, and one independent MRCC director joining the HRZN board.
• Investment advisors (MRCC Advisor and HRZN Advisor) are directly impacted, with MRCC's advisory agreement terminating and HRZN Advisor providing a fee waiver.
• Creditors and other financial stakeholders may see changes in the combined entity's financial structure and risk profile.

Next Steps

• HRZN and MRCC will jointly prepare and file a Registration Statement on Form N-14, including a Joint Proxy Statement/Prospectus, with the SEC.
• HRZN will use reasonable best efforts to have the Registration Statement declared effective and keep it effective.
• MRCC and HRZN will promptly mail the Joint Proxy Statement/Prospectus to their respective stockholders upon effectiveness.
• Both companies will convene stockholder meetings to obtain the required approvals for the merger and related matters.
• HRZN will seek approval for the listing of its common stock to be issued as merger consideration on Nasdaq.
• All necessary state securities law or blue sky permits and approvals will be obtained.
• Regulatory approvals, including the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, must be obtained.
• The Asset Purchase Agreement between MRCC, MCIP, and MRCC Advisor must be consummated immediately prior to the merger.
• The determination of both the Closing MRCC Net Asset Value and the Closing HRZN Net Asset Value must be completed.
• HRZN and HRZN Advisor will enter into a fee waiver agreement immediately after the Second Effective Time.
• The HRZN Board will be reconstituted to consist of four members: two independent HRZN members, the HRZN CEO, and one independent MRCC member.

Key Dates

Recommendation

While the merger presents a strategic positive for Horizon Technology Finance Corporation, offering increased scale and a fee waiver, its completion is contingent on several factors including shareholder and regulatory approvals, and the prior consummation of the Asset Purchase Agreement. The integration process and realization of anticipated synergies also carry inherent risks. A 'hold' recommendation is prudent for investors to monitor the progress of these conditions and assess the post-merger operational and financial performance before making further investment decisions.

Keywords

Merger, Acquisition, Business Development Company, BDC, Technology Finance, Monroe Capital, Horizon Technology Finance, SEC Filing, Investment Company Act, Corporate Governance, Financial Services